Based on these findings it is very well possible that several underlying disease mechanisms and disease-driving pathways are involved to varying degrees in different MLL-r leukemia subtypes (ALL vs AML), for different MLL translocations and even breakpoint localizations within the gene [42, 43]. Here, KMT2A is linked to leukemia.